Krish S. Krishnan - 26 Feb 2024 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Krish S. Krishnan
Issuer symbol
KRYS
Transactions as of
26 Feb 2024
Net transactions value
-$595,187
Form type
4
Filing time
28 Feb 2024, 21:36:40 UTC
Previous filing
12 Dec 2023
Next filing
01 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRYS Common Stock Tax liability $595,187 -3,791 -0.23% $157.00 1,630,547 26 Feb 2024 Direct F1, F2
holding KRYS Common Stock 1,574,206 26 Feb 2024 By Spouse F3
holding KRYS Common Stock 90,000 26 Feb 2024 By Krishnan Spousal Trust
holding KRYS Common Stock 50,000 26 Feb 2024 By Krishnan Family Trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 10,200 shares of restricted stock on February 26, 2024.
F2 The closing price on February 26, 2024 of the Company's common stock on NASDAQ.
F3 Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person.
F4 Directly beneficially owned by the Krishnan Family Trust. The Reporting Person and his spouse are each joint beneficial owners of the trust with joint voting and investment control.